Conflicts of Interest Brian Rini Research Funding to Institution: AVEO, Arcus, Merck, HiberCell, Incyte, Janssen, Adela, Astra-Zeneca, Tempus, Gilead, POINT Biopharma, BMS, Pfizer, Daiichi Sankyo, Genentech, Exelixis, Surface Oncology Consulting: Eisai, BMS, Pfizer, Astra-Zeneca, Aveo, Merck, Debiopharm, Exelixis, MashupMD, Xencor, Johnson and Johnson Thomas Powles MSD, Merck-Serono, Pfizer, GSK, Novartis, Roche, AZ, BMS, Exelexis, Ipsen, Seagen, Astellas, Jansen, Eisai, Mashup, Genentech, Natera, FMI, Takeda.